Research Directory

Alternative funding strategies for biotech

Read more

Unwinding the mystery behind TGN1412 -- New preclinical tests for immunology drugs

Read more

AXA Framlington looks for a bottom in biotech

Read more

Further antitrust scrutiny prescribed

Read more

Investors back NovImmune's antibody strategy

Read more

Pfizer commits to stem cell therapeutics

Read more

How consolidation may affect biotech innovation

Read more

Merck Serono Ventures invests in early technology

Read more

BIO: Industry finds ways to weather the storm

Read more

Pfizer commits to stem-cell therapeutics

Read more